MedTrace Logo

Ulinastatin Improves Postoperative Oxygenation After Cardiopulmonary Bypass

NCT03154814 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-05-16

No results posted yet for this study

Summary

Retrospective study determine whether ulinastatin enhances postoperative pulmonary oxygenation after cardiopulmonary bypass (CPB).

Conditions

  • Cardiopulmonary Bypass
  • Cardiac Surgery

Interventions

DRUG

ulinastatin

ulinastatin (10000 U/kg and 5000 U/kg/h) was administered during CPB

DRUG

control

conventional CPB was applied without ulinastatin treatment

Sponsors & Collaborators

  • Konkuk University Medical Center

    lead OTHER

Principal Investigators

  • Tae-yop Kim · Konkuk University Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2017-04-01
Completion
2017-05-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03154814 on ClinicalTrials.gov